Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
filingDate |
2003-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2006-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e82988b390bb793910a44d8debcd9dff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ddcd944f9ea584d3e32bc18fb956794 |
publicationDate |
2006-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2426492-C |
titleOfInvention |
A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease |
abstract |
Provided herein is a pharmaceutical composition comprising: (a) an effective amount of one or more of acetylcholinesterase inhibitors) or a pharmaceutically effective salt thereof; and (b) an effective amount of one or more NMDA-antagonist(s). Also provided is the use of the above composition for the manufacture of a medicament for the treatment of mild cognitive impairment or dementia. |
priorityDate |
2002-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |